In situ self-reassembling nanosystem enhances PD-L1 blockade for cancer immunotherapy
- 5 December 2024
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 377, 767-780
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Engineered bacterial membrane vesicle as safe and efficient nano-heaters to reprogram tumor microenvironment for enhanced immunotherapyJournal of Controlled Release, 2024
- Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancerJournal of Controlled Release, 2024
- Recent progress of metal‐based nanomaterials with anti‐tumor biological effects for enhanced cancer therapyExploration, 2023
- Biomimetic Nanocomposites Camouflaged with Hybrid Cell Membranes for Accurate Therapy of Early‐Stage GliomaAngewandte Chemie International Edition, 2023
- Engineered Bacterial Outer Membrane Vesicles as Controllable Two‐Way Adaptors to Activate Macrophage Phagocytosis for Improved Tumor ImmunotherapyAdvanced Materials, 2022
- Hybrid‐Membrane‐Decorated Prussian Blue for Effective Cancer Immunotherapy via Tumor‐Associated Macrophages Polarization and Hypoxia ReliefAdvanced Materials, 2022
- Self‐Blockade of PD‐L1 with Bacteria‐Derived Outer‐Membrane Vesicle for Enhanced Cancer ImmunotherapyAdvanced Materials, 2021
- cGAS phase separation inhibits TREX1-mediated DNA degradation and enhances cytosolic DNA sensingMolecular Cell, 2021
- Impact of Antigen Density on Recognition by Monoclonal AntibodiesAnalytical Chemistry, 2020
- Cell Membrane Coating Technology: A Promising Strategy for Biomedical ApplicationsNano-Micro Letters, 2019